G1 Therapeutics, Inc. (GTHX): Price and Financial Metrics
GTHX Price/Volume Stats
| Current price | $7.15 | 52-week high | $7.19 |
| Prev. close | $7.15 | 52-week low | $1.08 |
| Day low | $7.14 | Volume | 1,267,000 |
| Day high | $7.16 | Avg. volume | 1,701,154 |
| 50-day MA | $5.66 | Dividend yield | N/A |
| 200-day MA | $4.03 | Market Cap | 373.81M |
GTHX Stock Price Chart Interactive Chart >
G1 Therapeutics, Inc. (GTHX) Company Bio
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel therapeutics for the treatment of cancer in the United States. The company was founded in 2008 and is based in Research Triangle Park, North Carolina.
GTHX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | 222.07% |
| 1-year | 139.93% |
| 3-year | -34.88% |
| 5-year | -76.19% |
| YTD | 134.43% |
| 2023 | -43.83% |
| 2022 | -46.82% |
| 2021 | -43.25% |
| 2020 | -31.93% |
| 2019 | 38.02% |
Loading social stream, please wait...